News
Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...
Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” second quarter 2025 ...
Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 ...
Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second ...
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
Kirkland & Ellis advises Waters on $17.5B merger with Becton Dickinson, creating a diagnostics and life sciences leader.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed merger of Waters Corporation (NYSE: WAT) and Becton, ...
Major U.S. equities indexes were little changed at midday Monday, as investors weighed the potential impact of more U.S.
StockStory.org on MSN2d
Q1 Rundown: BD (NYSE:BDX) Vs Other Surgical Equipment & Consumables - Diversified StocksThe end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...
Private equity work is up year-over-year, but tariffs, inflation and valuations continue to be an issue for dealmakers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results